30.3 C
Vientiane
Wednesday, July 9, 2025
spot_img
Home Blog Page 325

VOC.AI Secures 15 Million Dollars Funding to Fuel Global Growth and Transform AI-Driven Customer Service Solutions

SILICON VALLEY, Calif., April 30, 2025 /PRNewswire/ — VOC.AI, a North America leader in AI-driven customer service solutions and intelligent insights, announced today the successful completion of a new multi-million-dollar funding round. The investment was led by Shanda Grab Ventures, in partnership with Northern Light Venture Capital and Starting Gate FundUnique Capital served as the exclusive financial advisor.

The funding will accelerate the development of VOC.AI’s AI-enabled agents and support its mission to boost workforce efficiency through intelligent, AI-driven customer service solutions. By implementing digital employees to manage repetitive and routine tasks, human teams are empowered to focus on higher-value, creative, and strategic work.

AI Agent technology is driving a paradigm shift in the global business ecosystem, especially in e-commerce, where intelligent customer experiences have become a core competitive factor,” said Cathy Ge, Deputy CIO of Shanda Grab Ventures. “VOC.AI’s strategic positioning places it at the forefront of this transformation. Its global smart infrastructure and regional capability matrix redefine the value chain of customer experience, introducing an evolutionary technology gene into the fundamental logic of cross-border commerce.”

A New Era of Customer Service AI

VOC.AI is redefining the enterprise software landscape with its pioneering AI Digital Employee, designed to deliver measurable outcomes instead of simply feature-stacking. Unlike traditional SaaS platforms, VOC.AI’s approach provides operational AI-powered agents that take full ownership of task execution and quality assurance. By combining efficient digital operations with seamless omnichannel integration, VOC.AI helps clients reduce recruitment costs without inflating SaaS spend—driving significant gains in both productivity and cost efficiency. This results-driven approach positions VOC.AI at the forefront of a new SaaS paradigm focused on performance, not just platform features and complexity.

The company’s flagship AI-powered customer service solution, Solvea, sets a new standard for intelligent support with its ‘Technology + Scenario + Compliance’ framework. Built on VOC.AI’s unified AI platform—which integrates generative AI, multi-agent architecture, and an e-commerce knowledge graph—Solvea delivers scalable, end-to-end solutions that drive faster resolution times, increase operational efficiency, and enhance customer satisfaction for leading global e-commerce brands and beyond.

Its AI-powered support agents seamlessly manage complex customer interactions at scale, including company-specific policies and cross-border returns, while providing real-time multilingual support, 24/7 availability, and enterprise-grade compliance with ISO 27001, SOC2 and GDPR standards.

2025 will be a defining year for AI-powered customer support, as its potential to transform the B2B ecosystem becomes undeniable, said Hunter Guo, Founder of VOC.AI. At VOC.AI, we’re committed to building world-class AI solutions that prioritize customer success and deliver measurable results. Our goal is to provide digital support agents that not only match—but surpass—live agent performance, setting new benchmarks for accuracy, resolution, and customer experience. We’re focused on delivering real business outcomes, not just software features.

VOC.AI AI-Powered CSR for E-Commerce Brands
VOC.AI AI-Powered CSR for E-Commerce Brands

Global Reach, Local Impact

VOC.AI’s core team includes alumni from top tech companies like Google, Alibaba, and ByteDance. Its AI models lead the industry in intent recognition, compliance and problem solving, and it has pioneered a pay-per-actual-service-results model, providing AI Agent services to more than 100 top brands.

As an early investor in VOC.AI, NLVC has witnessed VOC.AI’s continued exploration and outstanding execution in applying AI technology to real-world user scenarios, said Figo Zhang, Partner at Northern Light Venture Capital. VOC.AI has quickly established a competitive advantage in the cross-border brand e-commerce market, earning the trust and praise of numerous clients. Our decision to increase investment this time reflects our continued recognition of the VOC.AI team and confidence in its future growth potential.

VOC.AI Customer Reviews
VOC.AI Customer Reviews

Future-Focused Strategy

Looking ahead, VOC.AI will continue to build the next generation of AI capabilities – born in North America, built for the world. With a globally scalable architecture tailored to the customer service needs, VOC.AI is poised to lead the next revolution in AI-driven customer experience.

2025 is set to be a pivotal moment for AI agents, driven by significant advancements in engineering, ecosystem development, and the rapid iterations of foundational models. These breakthroughs are enabling the deep integration of AI agents across industries, enhancing operational efficiency and driving intelligent transformation, said Joe Wei, Founding Partner of Starting Gate Fund. One notable example is VOC.AI, which leverages its technological presence to penetrate niche scenarios effectively. With its AI R&D hub in Silicon Valley, VOC.AI is expanding localized operations in markets like North America and Japan while supporting the intelligent upgrades of e-commerce enterprises, accelerating AI adoption across industries.

About VOC.AI

VOC.AI is a global technology company providing artificial intelligence agent solutions for customer service. Its unified AI platform combines generative AI with real-time insights to provide AI Agent services to more than 100 top brands. Headquartered in North America, VOC.AI is redefining workforce productivity and customer experience across the globe, through next-generation AI-powered customer service solutions. Visit solvea.voc.ai for more information. 

Media Contact:
Email: support@voc.ai 
Website: solvea.voc.ai

Henley & Partners Responds to European Court of Justice Ruling on Malta’s Citizenship Program

LONDON, April 30, 2025 /PRNewswire/ — Henley & Partners is disappointed by the characterization of Malta’s citizenship program as an infringement of EU law or a “commercialization” of citizenship, as laid out in today’s highly politicalised judgment by the European Court of Justice (ECJ).

This ruling marks the conclusion of a case brought by the European Commission in March 2023. This case alleged that Malta’s citizenship by investment program violated the principle of sincere cooperation (a vague principle in EU law) and supposedly undermined the integrity of EU citizenship. However, the EU Commission, and now the ECJ’s reasoning, lacks a solid foundation in EU law, as many leading legal scholars and the Court’s own Advocate General have pointed out prior to today’s ruling.

Indeed, there is a stark contrast to the thoughtful and legally grounded opinion of the Advocate General, the ECJ’s lead judge, who concluded that the Maltese program did not infringe EU law and that the EU Commission had no case. The Court has now reversed course by a staggering 180 degrees and issued a judgement that appears politically motivated, as the reasoning provided by the court is tenuous at best. This undermines judicial consistency and confirms serious concerns about the increasing politicization of the EU’s legal institutions. It also undermines two of the most important values of the EU itself, democratic legitimisation and rule of law.

Dr. Christian H. Kälin, Chairman of Henley & Partners, says “the idea that investment migration undermines solidarity within the EU is not only unfounded but reflects a troubling misunderstanding of the socio-economic role these programs play. Malta’s framework exemplifies responsible nation-building — not opportunism. There are countless and major historic examples in Europe and elsewhere in the world. Rather than rejecting investment migration, the EU should focus on enhancing due diligence and harmonizing regulatory oversight to attract the right people to the Union who can contribute significantly and bring private investment, talent and entrepreneurship, which is urgently needed in Europe.”

He added that this judgment should not close the door to a more rational, fact-based conversation about the role of investment migration within the European project. Respecting national competences and fostering economic resilience — especially in smaller Member States — should be seen as part of a unified but diverse Europe.

Read full statement here

LoveStudy AI Launches Innovative AI Flashcard Generator Platform for Enhanced Learning

SHERIDAN, Wyo., April 30, 2025 /PRNewswire/ — LoveStudy AI announces a significant update to its AI Flashcards platform, initially launched on April 21.

This new iteration enhances the system’s ability to transform how students study and retain information. The platform leverages advanced cognitive science and adaptive AI technology to help users learn more efficiently and improve academic performance.

New Platform Transforms Traditional Study Methods

The traditional approach to creating study materials often involves hours spent manually writing flashcards. LoveStudy AI’s platform allows users to generate over 100 customized flashcards in under one minute by uploading notes, textbooks, or PDF documents. The system automatically extracts key concepts and creates optimized study tools.

“We believe education should be accessible to everyone,” said Jeffrey Jou, CEO of LoveStudy AI. “Our platform enables students to learn more effectively without the barriers of complex tools or subscription fees. Every registered user receives free credits to start learning smarter immediately.”

Cross-Platform Accessibility

LoveStudy AI Flashcards offers seamless synchronization across devices, allowing users to study on phones, tablets, and computers. Progress automatically updates across all platforms, enabling productive learning during otherwise idle moments.

Science-Based Learning Approach

LoveStudy AI integrates three established cognitive science principles:

  1. AI-powered content analysis that automatically converts educational materials into properly formatted question-and-answer pairs, prioritizing high-yield content specific to users’ learning objectives.
  2. An adaptive spaced repetition algorithm that addresses the Ebbinghaus forgetting curve by scheduling reviews at scientifically determined intervals, with increased exposure to challenging concepts.
  3. Active recall methodology that requires genuine information retrieval rather than passive recognition—a technique demonstrated to improve exam performance significantly compared to conventional study methods.

Specialized Applications

For standardized test preparation (MCAT, Bar exam, SAT, etc.), students can upload past papers to identify high-frequency test questions. The platform’s “Quiz Mode” generates tests focusing on knowledge gaps, helping users concentrate on mastering difficult material.

Language learners benefit from comprehensive “Word → Sentence → Pronunciation” flashcards that enhance vocabulary acquisition and contextual understanding, aligning with established best practices in language education.

About LoveStudy AI

Founded in 2025 and headquartered in the United States, LoveStudy AI develops next-generation educational technology solutions. The company offers three core products: AI-powered flashcards (AIFlashcard), intelligent note-taking tools (AINotes), and adaptive assessment systems (AIQuiz). LoveStudy AI is committed to making effective learning accessible to students worldwide through innovative technology.

Media Contact:
Lisa Brown
PR Manager, LoveStudy AI
Phone: +1 307-533-2034
Email: support@lovestudy.ai  

SecAI Debuts at RSA 2025, Redefining Threat Investigation with AI

By fusing agentic AI and contextual threat intelligence, SecAI transforms investigation from a bottleneck into a force multiplier.

SAN FRANCISCO, April 30, 2025 /PRNewswire/ — SecAI, an AI-enriched threat intelligence company, made its official debut today at RSA Conference 2025 in San Francisco, marking the company’s first public appearance on the global cybersecurity stage. At the event, the SecAI team is showcasing the latest version of its platform to security professionals from around the world.

The updated SecAI Investigator platform is purpose-built to solve one of cybersecurity’s most stubborn challenges: efficient threat investigation. It tackles this by combining two key innovations. First, it delivers curated, high-fidelity threat intelligence, which includes clear verdicts, multi-dimensional labels, and rich context like historical attack behavior through a unified interface. Second, it’s designed from the ground up with an AI-native architecture. The platform leverages advanced AI techniques not only for natural language interaction, but for deep information integration, contextual security reasoning, and suggest remediation options.

SecAI Booth At RSA Conference 2025, N-6570
SecAI Booth At RSA Conference 2025, N-6570

“We believe the future of cybersecurity lies in intelligent systems that can think and adapt like seasoned analysts,” said Chase Lee, Managing Director at SecAI. “Threat investigation has remained one of the most human-intensive parts of the SOC, but it doesn’t have to be. By combining deep threat intelligence with agentic AI, we’re not just accelerating investigations—we’re reshaping what’s possible in cyber defense. This is about giving security teams superhuman capabilities to meet the scale and speed of modern threats.”

In the security operations lifecycle—typically divided into detection, investigation, and response—automation has advanced detection and response dramatically over the past decade. But investigation remains a critical bottlenecks, often consuming over 70% of analysts’ time. SecAI believes that effective investigation depends on two essential capabilities: accurately gathering and organizing relevant information, and making sound, timely judgments. The main blockers today are:

  • A lack of timely, comprehensive threat intelligence
  • Ineffective methods for connecting data points to practical workflows

SecAI Investigator addresses both. By streamlining the investigation process, the platform enables analysts to rapidly evaluate the nature and relevance of IPs, domains, and threat actors, dive deep into logs and alerts, and make faster, more confident decisions.

Looking ahead, SecAI plans to roll out API and threat intelligence feed integrations, allowing customers to embed SecAI’s contextual threat intelligence directly into their existing systems and workflows. This will enable real-time enrichment, faster responses, and more scalable intelligence-driven operations across teams.

Visit SecAI Investigator to explore the platform or connect with the SecAI team at RSA Conference 2025 at Booth 6570 for live demos and early access.

About SecAI

SecAI is an AI-native cybersecurity company specializing in threat detection, investigation, and response. By deeply analyzing adversary tactics, techniques, and procedures (TTPs) and fusing advanced generative AI with rich, contextual threat intelligence, SecAI delivers smarter, faster, and more effective solutions for modern security teams. Our mission is to transform cybersecurity operations by empowering analysts with intelligent systems that scale expertise and accelerate decision-making.

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

  • Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations
  • Henlius to receive $31 million upfront, and up to $270 million in milestones

SHANGHAI, April 29, 2025 /PRNewswire/ — On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement with Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, granting exclusive commercialization rights for its self-developed ipilimumab biosimilar HLX13 in the United States, 42 European countries and regions, Japan, Canada, and Australia.

Under the agreement, Henlius will be responsible for development, manufacturing and commercial supply of HLX13, and is eligible to receive up to a total of $301 million, including a $31 million upfront and additional milestone payments. As the global leader in generic and biosimilar medicines, Sandoz is committed to its purpose of “pioneering access for patients” and has benefited over 900 million patients worldwide with approximately 1,300 products. This collaboration will leverage Sandoz’s established global network and commercialization expertise to accelerate the accessibility of HLX13 in mainstream biopharma markets.

“At Henlius, we remain deeply committed to delivering high-quality biologics to patients around the world,” said Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius. “Our collaboration with Sandoz marks another important step toward enhancing the global accessibility of our therapies. We believe that putting patients at the core of our globalization strategy is key to fulfilling our vision of ‘Developed in China, Access for the World.'”

“We’re excited to join forces with Sandoz,” said Ping Cao, Chief Business Officer and Senior Vice President of Henlius. “By combining Henlius’ proven strengths in biologics R&D and manufacturing with extensive global reach and commercialization expertise of Sandoz, we aim to accelerate the worldwide expansion of HLX13 and bring advanced treatment options to more patients across key markets.”

HLX13 is a key component of Henlius’ self-developed biosimilar pipeline. Its reference product, Yervoy®, the world’s first CTLA-4 inhibitor, has been approved in various countries and regions in combination with nivolumab for the treatment of melanoma and hepatocellular carcinoma, among other indications. Henlius has established an integrated global platform for R&D, regulatory registration, and clinical operations, backed by a manufacturing and quality management system that meets global regulatory standards. The company has successfully launched four products in markets beyond China. Henlius is committed to advancing the global development of HLX13 and working with partners to provide more high-quality, affordable treatment options for patients worldwide.

* Yervoy® is a registered trademark of Bristol-Myers Squibb (US)

About Henlius

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 6 products have been launched in China, 4 have been approved for marketing in overseas markets, and 5 marketing applications have been accepted for review in China, the U.S. and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP.

Henlius has pro-actively built a diversified and high-quality product pipeline covering about 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as the backbone. To date, the company’s launched products include HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANDAYUAN (adalimumab), HANBEITAI (bevacizumab), HANSIZHUANG (serplulimab, trade name: Hetronifly® in Europe), the world’s first anti-PD-1 mAb for the first-line treatment of SCLC, and HANNAIJIA (neratinib). What’s more, Henlius has conducted over 30 clinical studies for 19 products, expanding its presence in major markets as well as emerging markets.

 

Arkieva Announces Strategic Growth Investment from Banneker Partners

WILMINGTON, Del., April 29, 2025 /PRNewswire/ — Arkieva, a leading provider of supply chain planning software solutions, today announced a significant growth investment from Banneker Partners (Banneker). This strategic partnership marks a pivotal moment in Arkieva’s 30-year journey and is set to accelerate the company’s growth trajectory.

“We are thrilled to partner with Banneker Partners,” said Harpal Singh, CEO of Arkieva. “Their expertise in scaling software businesses and deep understanding of the supply chain industry will be invaluable as we enter our next phase of growth. This investment will enable us to enhance our innovative solutions and better serve our global customers.”

Arkieva has established itself as a category-leading supply chain planning software provider, trusted by global manufacturers and distributors to manage $110 billion in revenue planning. The company’s modern Software as a Service (SaaS) solutions offer unrivaled digital twin and autonomous control tower capabilities, addressing critical issues such as poor visibility, shifting labor inputs, global instability and sustainability concerns.

“We are pleased to partner with Arkieva and support their mission to drive innovation in the process manufacturing sector,” said Kenneth Frank, Partner at Banneker. “This investment demonstrates Banneker’s commitment to fostering innovation and supporting companies that are shaping the future of supply chain technology.”

The investment from Banneker Partners aims to equip Arkieva for a new phase of growth, enabling the company to sustain its leading position and address evolving market demand.

“Arkieva is a unique software company that serves the needs of the process manufacturing industry and provides clear return on investment,” commented Harjot Sachdeva, Operating Partner at Banneker. “We are committed to supporting Arkieva as they continue to deliver exceptional value to their customers and drive industry innovation.”

This partnership is expected to:

  • Facilitate inorganic growth and accelerate Arkieva’s current trajectory
  • Leverage Banneker’s proven track record in scaling excellence across industry verticals
  • Implement a robust value creation plan harnessing deep expertise

Dhiran Singh, Executive VP of Arkieva, commented, “Joining forces with Banneker Partners is a natural step in our mission to empower businesses with smarter, more agile planning solutions. By combining our strengths, we can offer manufacturers an unparalleled suite of tools that integrates planning, scheduling and execution, ultimately driving greater business performance.”

“Brown Gibbons Lang & Company (BGL) was pleased to advise Arkieva in securing a strategic partnership with Banneker Partners. This collaboration brings together Banneker’s operating experience and extensive track record in supply chain and manufacturing with Arkieva’s leading planning and scheduling software solution for the process industry,” said Scott Mattson, Head of BGL’s Technology investment banking team. “This new partnership will help Arkieva accelerate product innovation and drive greater value to their customers,” added Michael Magruder, Managing Director of BGL’s Supply Chain Software investment banking team.

About Arkieva

For more than 30 years, Arkieva has helped global enterprises drive business transformation through improved supply chain processes. The company’s demand, inventory, supply and integrated business planning solutions increase growth and profits, and provide the agility and efficiency needed to respond to an ever-changing supply chain environment. Our approach combines strategic consultation, powerful software technologies and iterative implementation to deliver scalable solutions tailored to the complexities of each customer’s operations. Arkieva’s culture of innovation keeps customers like Wells Enterprises, Bakelite Synthetics and Momentive Performance Materials at the forefront of supply chain planning.

Arkieva is headquartered in Wilmington, Delaware USA with offices in Antwerp, Belgium and Mangalore, India. For more information, visit www.arkieva.com.

CONNECT WITH ARKIEVA

Arkieva Media Contact:

Kristan Theile
Director of Marketing, Arkieva
513-376-0300
ktheile@arkieva.com 

About Banneker Partners

Banneker Partners invests in growing, mission-critical enterprise software businesses to drive sustainable long-term value. They take a partnership approach to support founders and management teams, implementing proven best practices and making strategic investments to enhance customer value.

About Brown Gibbons Lang & Company

Brown Gibbons Lang & Company (BGL) is a leading independent investment bank focused on the global middle market. The firm advises private and public corporations and private equity groups on mergers and acquisitions, divestitures, capital markets, financial restructurings, valuations and opinions, real estate and other strategic matters. BGL has investment banking offices in Boston, Chicago, Cleveland, Los Angeles and New York.

 

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

  • Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations
  • Henlius to receive $31 million upfront, and up to $270 million in milestones

SHANGHAI, April 29, 2025 /PRNewswire/ — On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement with Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, granting exclusive commercialization rights for its self-developed ipilimumab biosimilar HLX13 in the United States, 42 European countries and regions, Japan, Canada, and Australia.

Under the agreement, Henlius will be responsible for development, manufacturing and commercial supply of HLX13, and is eligible to receive up to a total of $301 million, including a $31 million upfront and additional milestone payments.  As the global leader in generic and biosimilar medicines, Sandoz is committed to its purpose of “pioneering access for patients” and has benefited over 900 million patients worldwide with approximately 1,300 products. This collaboration will leverage Sandoz’s established global network and commercialization expertise to accelerate the accessibility of HLX13 in mainstream biopharma markets.

HLX13 is a key component of Henlius’ self-developed biosimilar pipeline. Its reference product, Yervoy®, the world’s first CTLA-4 inhibitor, has been approved in various countries and regions in combination with nivolumab for the treatment of melanoma and hepatocellular carcinoma, among other indications. Henlius has established an integrated global platform for R&D, regulatory registration, and clinical operations, backed by a manufacturing and quality management system that meets global regulatory standards. The company has successfully launched four products in markets beyond China. Henlius is committed to advancing the global development of HLX13 and working with partners to provide more high-quality, affordable treatment options for patients worldwide.

 

 

Jollibee Group recognized anew with Gallup Exceptional Workplace Award

Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award


MANILA, PHILIPPINES – Media OutReach Newswire – 29 April 2025 – The Jollibee Group, one of the world’s fastest-growing restaurant companies, has once again been recognized for its commitment to fostering a joyful workplace culture. For the fourth time, the company has received the Gallup Exceptional Workplace Award (GEWA)—a prestigious global recognition given to organizations that set the benchmark for employee engagement and performance.

Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award
Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award

Jollibee Group remains the only Philippine-based company to receive this honor, standing alongside a select group of organizations worldwide that have successfully embedded employee engagement as a core driver of their business strategy.

“Our continued recognition as an employer of choice affirms what we’ve always believed –that our people are the driving force of our success,” said Ernesto Tanmantiong, Jollibee Group’s Global President and Chief Executive Officer. “This award is a testament to the passion and dedication of our teams worldwide who bring joy to our customers and one another every day.”

“We remain committed to nurturing a workplace culture where our people can thrive, grow, and find purpose in what they do,” added Tanmantiong.

“Congratulations to this year’s Gallup Exceptional Workplace Award winners for setting the standard for a thriving workplace. By prioritizing both people and performance, you are shaping the future of work and proving that exceptional workplaces drive real results,” said Jon Clifton, Gallup’s chief executive officer.

Recognized Employer of Choice

This latest recognition comes on the heels of the company’s recognition as 2024’s “Employer of the Year” by the People Management Association (PMAP)—the premier and largest association of people managers in the Philippines. This comes after a rigorous competitive process involving other major companies in the country.

Jollibee Group’s Global Chief Human Resources Officer, Arsenio “Archie” Sabado, was also recognized as People Manager of the Year by PMAP, recognizing his role in shaping the company’s joyful culture.

The Jollibee Group was also included in TIME Magazine’s list of the World’s Best Companies for 2024 and made the FORTUNE 500’s inaugural Southeast Asia list.

The company employs over 31,000 people worldwide, with a footprint spanning 9,700 stores in 32 countries across its 19 brands. To learn more about the Jollibee Group, visit www.jollibeegroup.com. To learn more about the Gallup Exceptional Workplace Awards, visit https://www.gallup.com/workplace/657323/announcing-2025-gallup-exceptional-workplace-award-winners.aspx.

Hashtag: #JollibeeGroup

The issuer is solely responsible for the content of this announcement.

About Jollibee Group

Jollibee Foods Corporation (JFC), also known as the Jollibee Group, is one of the world’s fastest-growing restaurant companies, with a mission to deliver great-tasting food, bringing the joy of eating through its 19 brands with over 9,700 stores across 32 countries.

The Jollibee Group’s portfolio includes nine wholly owned brands (Jollibee, Chowking, Greenwich, Red Ribbon, Mang Inasal, Yonghe King, Hong Zhuang Yuan, Smashburger and Tim Ho Wan), five franchised brands (Burger King, Panda Express, Yoshinoya, Common Man Coffee Roasters, and Tiong Bahru Bakery in the Philippines), and ownership stakes in other key brands like The Coffee Bean and Tea Leaf (80%), Compose Coffee (70%), SuperFoods Group that operates Highlands Coffee (60%), and bubble tea brand Milksha (51%). The Company also has membership interests in Tortazo, LLC, along with Chef Rick Bayless, for Tortazo in the U.S. and has recently invested in Botrista, a leader in beverage technology.

The Jollibee Group’s global sustainability agenda, Joy for Tomorrow, underscores its commitment to sustainable business practices across food safety, employee welfare, community support, good governance, and environmental responsibility, among others. These focus areas are aligned with the United Nations Sustainable Development Goals (UN SDGs).

The Jollibee Group has been recognized as the Philippines’ Most Admired Company by the Asian Wall Street Journal, named one of Asia’s Fab 50 Companies, and listed among Forbes’ World’s Best Employers and Top Female-Friendly Companies. The Company is also a three-time Gallup Exceptional Workplace Award recipient and featured in TIME’s World’s Best Companies and Fortune’s Southeast Asia 500 List.

To learn more about Jollibee Group, visit